Protein-capped mesoporous silica SBA-15 enables protease-responsive and controlled antimicrobial peptide delivery

Abstract

Mesoporous silica materials are promising carriers for antimicrobial peptides (AMPs), offering a versatile platform for combating bacterial infections. However, achieving high loading efficiency and controlled AMP release under physiological conditions remains a challenge. This study introduces a protein-capped mesoporous silica-based delivery system for treating topical bacterial infections. The system leverages elevated protease activity at infection sites to trigger the release of the sequence-optimized antimicrobial lipopeptide L-6-C5 (SOAP), facilitating efficient bacterial killing. SOAP was loaded into aminopropyl-functionalized SBA-15 mesoporous silica (amino-SBA-15) and capped with bovine serum albumin (BSA) or casein, forming amino-SBA-15-SOAP@protein. Protein adsorption prevented premature SOAP release while enabling protease-triggered delivery. BSA capping achieved 92.6 ± 0.2 % loading efficiency and enhanced peptide retention by 4.5-fold compared to non-capped particles, while casein yielded only a 1.25-fold increase. In the absence of proteases, SOAP release followed first-order kinetics, resulting in sustained release over 6 days. When exposed to trypsin, the release mechanism changed from diffusion-based to anomalous non-Fickian transport with zero-order kinetics, enabling rapid and efficient SOAP release. Proteolytic degradation of the protein cap also accelerated particle degradation and aggregation, offering insights into release dynamics under physiological conditions. The BSA-capped systems (amino-SBA-15-SOAP@BSA) showed effective bacteriostatic activity against Staphylococcus aureus (S. aureus), low hemolytic activity, and high cytocompatibility toward human dermal fibroblasts, outperforming free SOAP. Additionally, BSA capping reduced nonspecific protein binding in serum-rich media. By integrating sustained SOAP delivery with protease-triggered release, the amino-SBA-15-SOAP@BSA system addresses key limitations in AMP delivery, providing a promising strategy for controlled and localized AMP delivery in the treatment of topical bacterial infections.